{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:34:24Z","timestamp":1777340064269,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ajog.2023.12.036","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T03:22:19Z","timestamp":1704338539000},"page":"434.e1-434.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of breakthrough bleeding in transgender and gender-diverse individuals on long-term testosterone"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-724X","authenticated-orcid":false,"given":"Frances W.","family":"Grimstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Boskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael S.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile A.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.12.036_bib1","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2023.12.036_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","article-title":"Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder","volume":"60","author":"Nakamura","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2023.12.036_bib4","doi-asserted-by":"crossref","first-page":"e1290","DOI":"10.1210\/clinem\/dgaa884","article-title":"Efficacy of sex steroid therapy without progestin or GnRH agonist for gonadal suppression in adult transgender patients","volume":"106","author":"Pappas","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2023.12.036_bib5","first-page":"3002","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J\u00a0Sex Med"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.12.036_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"10.1016\/j.ajog.2023.12.036_bib7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1080\/13691058.2016.1182645","article-title":"Queer periods: attitudes toward and experiences with menstruation in the masculine of centre and transgender community","volume":"18","author":"Chrisler","year":"2016","journal-title":"Cult Health Sex"},{"key":"10.1016\/j.ajog.2023.12.036_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000003308","article-title":"Approaches to vaginal bleeding and contraceptive counseling in transgender and gender nonbinary patients","volume":"134","author":"Schwartz","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpag.2016.01.100","article-title":"Menstrual suppression and contraceptive choices in a transgender adolescent and young adult population","volume":"29","author":"Kanj","year":"2016","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/AOG.0000000000004899","article-title":"General approaches to medical management of menstrual suppression: ACOG Clinical Consensus No. 3","volume":"140","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4158\/EP-2017-0203","article-title":"Estrogen levels do not rise with Testosterone treatment for transgender men","volume":"24","author":"Chan","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2023.12.036_bib12","first-page":"41","article-title":"Reproductive endocrinology reference intervals for transgender men on stable hormone therapy","volume":"6","author":"Greene","year":"2021","journal-title":"J\u00a0Appl Lab Med"},{"key":"10.1016\/j.ajog.2023.12.036_bib13","doi-asserted-by":"crossref","first-page":"229.e1","DOI":"10.1016\/j.ajog.2020.01.059","article-title":"The effect of testosterone on ovulatory function in transmasculine individuals","volume":"223","author":"Taub","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib14","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2018.12.021","article-title":"Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series","volume":"220","author":"Grimstad","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/PGP.0000000000000548","article-title":"Histologic Features of hysterectomy specimens from female-male transgender individuals","volume":"38","author":"Khalifa","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2023.12.036_bib16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.fertnstert.2020.11.008","article-title":"Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy","volume":"115","author":"Hawkins","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.12.036_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/AOG.0000000000004421","article-title":"Clinical characteristics and histologic features of hysterectomy specimens from transmasculine individuals","volume":"138","author":"Cao","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib18","first-page":"1807","article-title":"Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series","volume":"17","author":"Grimstad","year":"2020","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ajog.2023.12.036_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpag.2021.04.004","article-title":"Breakthrough bleeding in transgender and gender diverse adolescents and young adults on long-term testosterone","volume":"34","author":"Grimstad","year":"2021","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/trgh.2017.0021","article-title":"Induction and maintenance of amenorrhea in transmasculine and nonbinary adolescents","volume":"2","author":"Carswell","year":"2017","journal-title":"Transgend Health"},{"key":"10.1016\/j.ajog.2023.12.036_bib21","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000001215","article-title":"ACOG Committee Opinion No. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2023.12.036_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2023.12.036_bib24","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"ACOG Practice Bulletin No. 194: polycystic ovary syndrome","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-Part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2023.12.036_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00006250-200403000-00045","article-title":"ACOG practice bulletin no. 51. chronic pelvic pain","volume":"103","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib27","series-title":"Emans, Laufer, Goldstein\u2019s pediatric and adolescent gynecology","author":"Emans","year":"2011"},{"key":"10.1016\/j.ajog.2023.12.036_bib28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jpag.2020.06.001","article-title":"Dysmenorrhea and endometriosis in transgender adolescents","volume":"33","author":"Shim","year":"2020","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940700021X","article-title":"Endometriosis: disease pathophysiology and the role of prostaglandins","volume":"9","author":"Wu","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.ajog.2023.12.036_bib30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Primary dysmenorrhea: advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib31","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jmig.2021.01.018","article-title":"Preoperative pain symptoms and the incidence of endometriosis in transgender men undergoing hysterectomy for gender affirmation","volume":"28","author":"Ferrando","year":"2021","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpag.2019.11.011","article-title":"Adolescent endometriosis: an update","volume":"33","author":"Shim","year":"2020","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tjog.2016.03.004","article-title":"Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals","volume":"55","author":"Loverro","year":"2016","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.036_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/IJWH.S46680","article-title":"Menstrual suppression: current perspectives","volume":"6","author":"Hillard","year":"2014","journal-title":"Int J Womens Health"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:38:34Z","timestamp":1777336714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0002937824000024"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.12.036","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of breakthrough bleeding in transgender and gender-diverse individuals on long-term testosterone","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}